Income Tax Expense (Benefit) in USD of NRX Pharmaceuticals, Inc. from Q4 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q1 2025.
  • NRX Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $0.000.
  • NRX Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.000.
  • NRX Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • NRX Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $17.8K, a 78.8% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

NRX Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 -$5.36K $0 +$42.7K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$48K $0 +$6.74K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$54.8K $0 -$72.6K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $17.8K -$5.36K -$1.43K -36.6% Oct 1, 2020 Dec 31, 2020 10-K/A 2021-05-14
Q3 2020 $19.3K -$42.7K -$58.4K -371% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $77.7K -$6.74K -$47.4K -117% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $125K $72.6K +$40.9K +129% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q4 2019 $84.2K -$3.92K +$27.8K +87.6% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-05-14
Q3 2019 $56.4K $15.7K -$19.3K -55% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $75.6K $40.7K +$31.7K +355% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $43.9K $31.7K +$27.6K +671% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $16.3K -$31.7K -$31.7K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $48.1K $35K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $8.95K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $4.12K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $0 Sep 18, 2017 Dec 31, 2017 10-K 2019-03-15

NRX Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 Jan 1, 2024 Dec 31, 2024 10-K 2025-03-14
2023 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-14
2020 $17.8K -$66.4K -78.8% Jan 1, 2020 Dec 31, 2020 10-K/A 2021-05-14
2019 $84.2K +$67.9K +416% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-14
2018 $16.3K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.